Showing results (131-140 of 212) with videos related to

Sort By:
Pageof 22
Circulation|July 22, 2016
Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial InfarctionErin A Bohula, Marc P Bonaca, Eugene Braunwald, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 1, 2018
Antithrombotic therapy use and clinical outcomes following thrombo-embolic events in patients with atrial fibrillation: insights from ARISTOTLEShinya Goto, Peter Merrill, Lars Wallentin, et al.
International Journal of Cardiology|July 17, 2012
Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: insights from the EARLY ACS trialRenato D Lopes, Jennifer A White, Pierluigi Tricoci, et al.
American Heart Journal|December 5, 2016
On-treatment analysis of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT)Michael A Blazing, Robert P Giugliano, James A de Lemos, et al.
Circulation|September 1, 2010
Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trialStefan James, Andrzej Budaj, Philip Aylward, et al.
European Heart Journal|July 19, 2021
Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapyVictor Aboyans, Rupert Bauersachs, Lucia Mazzolai, et al.
Lancet (London, England)|August 31, 2012
Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trialBenjamin M Scirica, Marc P Bonaca, Eugene Braunwald, et al.
American Heart Journal|February 16, 2018
Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trialMatthew W Sherwood, Renato D Lopes, Jie Lena Sun, et al.
Lancet (London, England)|January 19, 2010
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind studyChristopher P Cannon, Robert A Harrington, Stefan James, et al.
Circulation|November 15, 2017
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)Marc P Bonaca, Patrice Nault, Robert P Giugliano, et al.
Pageof 22